TCPAland truly is a hotbed of statutory interpretation. As we eagerly await the ruling on the FCC’s Public Notice concerning the interpretation and scope of the TCPA in the wake of the ACA Int’l ...
Because it is impossible to design a prescription drug that provides the desired health benefits with zero risk of harm, courts have long held that manufacturers of prescription drugs are not strictly ...